Orphan drugs face “uphill battle” in 2020
EMA-assigned Orphan Drug Designations declined 49% between 2014 and 2019.
Read More
Tag: GlobalData
Heart failure market could surpass ‘$22bn by 2028’
Due to the aging global population, recent years have seen an increased prevalence of chronic HF.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
